Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pamrevlumab (1 trial)
nd-l02-s0201 (1 trial)
tiotropium (spiriva) (1 trial)
Fibrosis (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Pulmonary Fibrosis (Phase 2)
Trials (3 total)
Trial APIs (3 total)